Plain-English translation of NCT06482853 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Researchers want to understand whether a medication called can help lower blood pressure and reduce stress on the heart in people who have obesity and high blood pressure. This is an early-stage study that will give the medication intravenously (through an IV) to see how it affects blood pressure, heart rate, and blood vessel function. The study compares the medication to a saline placebo to see if there are real benefits.
High blood pressure and obesity often occur together and increase the risk of heart disease. Current treatments don't work perfectly for everyone, so doctors are exploring whether this medication might offer a new way to help manage blood pressure and protect the heart in this population.
You likely qualify if…
You likely don't qualify if…
You'll come to the clinic for a screening visit, and then return for two study visits about a week apart, each lasting about 4 hours. During each study visit, you'll receive an IV infusion for 2 hours — either the new medication at gradually increasing doses or a saline placebo. Throughout the visits, researchers will continuously monitor your blood pressure, heart rate, and nerve activity, and will take blood samples and measure how well your blood vessels are functioning.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United States